Oxford Biomedica plc
OXB.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£47 | -£157 | -£46 | £20 |
| Dep. & Amort. | £22 | £29 | £26 | £12 |
| Deferred Tax | £0 | £0 | £0 | £1 |
| Stock-Based Comp. | £0 | £4 | £6 | £4 |
| Change in WC | -£34 | £17 | £5 | -£13 |
| Other Non-Cash | £9 | £79 | -£4 | £1 |
| Operating Cash Flow | -£51 | -£29 | -£13 | £25 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£7 | -£10 | -£16 | -£9 |
| Net Acquisitions | £9 | £0 | -£99 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £4 | £13 | £59 | £0 |
| Investing Cash Flow | £6 | £3 | -£56 | -£9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£0 | -£3 | £33 | -£5 |
| Stock Issued | £18 | £1 | £80 | £52 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£14 | -£10 | -£15 | -£1 |
| Financing Cash Flow | £3 | -£13 | £99 | £46 |
| Forex Effect | -£1 | £1 | £3 | £0 |
| Net Chg. in Cash | -£43 | -£38 | £32 | £62 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £104 | £141 | £109 | £47 |
| End Cash | £61 | £104 | £141 | £109 |
| Free Cash Flow | -£58 | -£38 | -£29 | £16 |